FINWIRES · TerminalLIVE
FINWIRES

$LONN.SW

3 stories mentioning LONN.SW

Every FINWIRES story that references LONN.SW, newest first.

Asia Markets

Swiss Market Index Closes Lower; Logitech Shares Jump

The Swiss Market Index was in negative territory on Friday, ending the trading session 0.27% lower amid a flurry of corporate releases and economy-related data prints.Government data showed that Switzerland's consumer sentiment index rose to -40 points in April from -42.9 points in March. In the previous year, the index came in at -42.4 points. The State Secretariat for Economic Affairs said the separate indices for economic outlook and past financial situation improved year over year, whereas the index for financial outlook "barely changed." On the other hand, the indicator for moment to make major purchases deteriorated.Over to corporates, Logitech International (LOGN.SW) saw its shares jump 3.03% as it initiated its new three-year share repurchase program worth $1.4 billion as part of plans to buy back $2 billion in shares over the period. The new program follows the completion of the Swiss computer peripherals and software company's $1.6 billion buyback that began in 2023.Pharmaceutical manufacturer Lonza Group (LONN.SW) was 0.66% lower at close after confirming its sales growth guidance of between 11% and 12% at constant exchange rates. Lonza forecasts low-teens percentage sales growth at constant exchange rates in the mid-term."In light of macro uncertainty and tariff concerns, we think that this update - with its combination of demand reassurance, guidance reaffirmation and CHI exit timelines - should be taken well by investors, who largely still view Lonza as a long-term compounder," RBC Capital Research said in a quick take note.

^SSMI$LOGN.SW$LONN.SW
Asia Markets

Swiss Market Index Closes Little Changed; Santhera Shares Jump

The blue-chip Swiss Market Index was down 0.03% on Monday's close, as investors gear up for a busy week of corporate updates, economic data prints and key monetary policy decisions.Santhera Pharmaceuticals (SANN.SW) secured a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use to expand the approval of its Duchenne muscular dystrophy drug Agamree to include the treatment of children who are at least two years old. The drug is currently approved for use on patients aged four and above. The Swiss specialty pharmaceutical company's shares gained 8.38% at closing.Meanwhile, RBC Capital Markets reiterated its outperform rating on Lonza Group (LONN.SW), with a price target of 670 francs, amid expectations that the Swiss pharmaceutical manufacturer's upcoming first-quarter update would be "uneventful." At the end of the trading day, the stock was up 1.83%."We do not see the Q1 qualitative update on 8 May to be a major catalyst for the stock now that Vacaville-specific commentary will no longer be provided, and any further weakness in Specialized Modalities should not be a surprise. We have also taken the opportunity to refresh and add to our commercial product (Enflonsia) and pipeline trackers. There has been some clinical progress, but consensus forecasts have been pushed out a little (aggregate peak sales estimates are unchanged)," the research firm said, noting that it views Lonza as an "attractive and undervalued compounding investment story."The local economic news calendar was empty for the day, while the release of the Swiss KOF Economic Barometer and the UBS & CFA Society Switzerland's economic sentiment index for April, as well as the country's March retail sales figures are on the agenda over the coming days. Market watchers are also awaiting the rate decisions of the US Federal Reserve, the European Central Bank, and the Bank of England.

^SSMI$LONN.SW$SANN.SW
Research

AlphaValue/Baader Europe Upgrades Lonza Group to Buy, Lifts PT

AlphaValue/Baader Europe on Monday upgraded Swiss pharmaceutical manufacturer Lonza Group (LONN.SW) to buy from add and raised its price target to 646 francs from 644 francs.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LONN.SW
LONN.SW News | FINWIRES